A conversation about COVID-19
Associate Professor van der Walt discusses the latest information on COVID-19, its impact on people living with multiple sclerosis and some strategies to deal with them.
Associate Professor Anneke van der Walt, Neurologist at Alfred Health in Melbourne chats with Jodi Haartsen, Executive Manager at MS Plus about the COVID vaccines that have been approved in Australia and their impact on people living with MS.
Presenter
Associate Professor Anneke van der Walt is an academic Neurologist with subspecialty training in multiple sclerosis and neuroimmunology as well as neuro-ophthalmology. She leads the MS and Neuro-ophthalmology Research Group at the Central Clinical School, Monash University.
Published December 2020
Related resources
Mental Resilience during COVID-19
In this episode we discuss tips and strategies for managing our mental health and building mental resilience during COVID-19.
FAQ about COVID-19 and MS
We have received many questions from our clients about how COVID-19 might impact the health and wellbeing of people living with MS. Here are the answers to the most frequently asked questions.
